Rapid risk assessment: Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae

risk assessment
Cite:
Citation Link

European Centre for Disease Prevention and Control. Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae – 12 June 2018.  Stockholm; ECDC; 2018. 

Copy citation to clipboard

This risk assessment will discuss CAZ-AVI resistance in brief, review the recent literature reporting resistance of CRE to CAZ-AVI, and assess the risk for the EU/EEA countries. It will outline options for appropriate detection of resistance and the correct and timely implementation of IPC measures to prevent spread of these highly resistant organisms within healthcare settings and across borders.

Related content

Publication

ECDC country visit to Norway to discuss antimicrobial resistance issues

mission report -

Publication

Expert consensus protocol on colistin resistance detection and characterisation for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae

protocol -

Publication

Expert consensus protocol on carbapenem resistance detection and characterisation for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae

protocol -

Publication

Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals - ECDC PPS validation protocol version 3.1.2.

technical report -

News

OECD highlights the progress made in laboratory systems in the EU/EEA since the implementation of EULabCap

ECDC comment -